Nestle
I · AI Analysis
The brief
Nestlé makes and sells food and drinks you see in grocery stores worldwide — coffee brands like Nescafé and Starbucks At Home, chocolate bars like KitKat, frozen foods like DiGiorno pizza, ice cream like Häagen-Dazs, bottled water like Perrier, and pet food like Purina [Company Overview]. They operate across multiple regions including North America, Europe, Asia, Latin America, and China, selling both global brands and local products tailored to each market [Company Overview].
Nestlé is a massive Swiss food and beverage company with 271,000 employees, selling everything from coffee (Nescafé, Nespresso) and chocolate (KitKat) to pet food (Purina) and bottled water (Perrier, S.Pellegrino). The company has a market cap of CHF 202.6 billion but recently saw revenue decline 2.2% year-over-year to CHF 89.9 billion [Yahoo Finance]. Despite solid profit margins, the company carries moderate financial concerns due to elevated debt levels.
Nestlé is profitable with healthy margins, but revenue is shrinking and debt levels are elevated.
Sentinellis health
6.3/10
Moderate concerns
Market capitalisation
CHF 202.6B
Revenue (TTM)
CHF 89.9B
II · Recent news
What moved
1 stories · ranked by relevance
- macro2026-04-17
Nestle India Share Price Live Updates: Nestle India's beta suggests stable market behavior
The Economic Times
Premium · Free with any account
Revenue is declining: the company saw a 2.2% drop in revenue year-over-year, signaling either weakening demand or pricing pressures [Yahoo Finance].
Risks
4
Opportunities
4
Red flags
2
Leadership
10
9 more findings in the full report — free with any account.
Unlock the full Nestle analysis
Create a free account to access the complete AI-generated report with inline citations.
- 4 risks, 4 opportunities and 2 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Consumer Defensive or comparable health
Want this for your watchlist?